Skip to main content
. Author manuscript; available in PMC: 2010 Nov 22.
Published in final edited form as: J Immunol. 2009 Apr 15;182(8):4616–4623. doi: 10.4049/jimmunol.0801279

Table I.

MHC-II, CD40, CD80, and CD86 expression on BMDC: cells treated with NECA and LPS are compared to relevant controlsa

Mean Fluorescence Intensity
MHC-II CD40 CD80 CD86
Media 993 ± 81 5.6 ± 0.3 343 ± 65 317 ± 47
Vehicle + LPS 1060 ± 60 11.8 ± 1.1 1111 ± 323 927 ± 107
NECA + LPS 781 ± 52* 8.9 ± 0.4 1131 ± 304 616 ± 87*
a

Averaged mean fluorescence intensity ± SEM from three or more experiments.

*

p < 0.05.